Skip to main content

Table 2 Association between TOP2A expression and biochemical recurrence-free survival

From: Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer

TOP2A intensity Median (months) p*
1+ (weak) 60.230 0.001
2+ (moderate) 29.375
3+ (strong) 16.743  
  1. * Statistically significant p values inferior to 0.05.